Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute, 40781 [2014-16317]
Download as PDF
Federal Register / Vol. 79, No. 134 / Monday, July 14, 2014 / Notices
Dated: July 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2014–16317 Filed 7–11–14; 8:45 am]
[Docket No. DEA–392]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before September 12, 2014.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7(g) of 28 CFR part
0, subpart R, Appendix.
In accordance with 21 CFR
1301.33(a), this is notice that on April
4, 2014, Research Triangle Institute,
Kenneth S. Rehder, Ph.D., Hermann
Building East Institute Drive, P.O. Box
12194, Research Triangle Park, North
Carolina 27709, applied to be registered
as a bulk manufacturer of the following
basic classes controlled substances:
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Cocaine (9041) .............................
I
I
II
The company will manufacture
marihuana and cocaine derivatives for
use by their customers in analytical kits,
reagents, and reference standards as
directed by the National Institute on
Drug Abuse.
VerDate Mar<15>2010
19:25 Jul 11, 2014
Jkt 232001
Under
Executive Orders 12073 and 10582, the
DOL issues an annual list of Labor
Surplus Areas (LSA) used by Federal
and State entities in a number of actions
such as procurement and property
transfer. The annual LSA list is updated
during the year, based upon petitions
submitted to the DOL by State
Workforce Agencies requesting
additional areas for LSA certification.
This information collection is specified
by regulations 20 CFR part 654.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid Control Number. See 5
CFR 1320.5(a) and 1320.6. The DOL
obtains OMB approval for this
information collection under Control
Number 1205–0207.
OMB authorization for an ICR cannot
be for more than three (3) years without
renewal, and the current approval for
this collection is scheduled to expire on
July 31, 2014. The DOL seeks to extend
PRA authorization for this information
collection for three (3) more years,
without any change to existing
requirements. The DOL notes that
existing information collection
requirements submitted to the OMB
receive a month-to-month extension
while they undergo review. For
additional substantive information
about this ICR, see the related notice
published in the Federal Register on
March 27, 2014 (79 FR 17183).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within thirty (30) days of
publication of this notice in the Federal
Register. In order to help ensure
appropriate consideration, comments
should mention OMB Control Number
1205–0207. The OMB is particularly
interested in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
SUPPLEMENTARY INFORMATION:
Notice of application.
Controlled substance
Michel Smyth by telephone at 202–693–
4129, TTY 202–693–8064, (these are not
toll-free numbers) or by email at DOL_
PRA_PUBLIC@dol.gov.
Authority: 44 U.S.C. 3507(a)(1)(D).
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
ACTION:
40781
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Petition
for Classifying Labor Surplus Areas
ACTION:
Notice.
The Department of Labor
(DOL) is submitting the Employment
and Training Administration (ETA)
sponsored information collection
request (ICR) titled, ‘‘Petition for
Classifying Labor Surplus Areas,’’ to the
Office of Management and Budget
(OMB) for review and approval for
continued use, without change, in
accordance with the Paperwork
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq. Public comments on the
ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before August 13, 2014.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov Web site at https://www.
reginfo.gov/public/do/PRAViewICR?ref_
nbr=201405-1205-001 (this link will
only become active on the day following
publication of this notice) or by
contacting Michel Smyth by telephone
at 202–693–4129, TTY 202–693–8064,
(these are not toll-free numbers) or by
email at DOL_PRA_PUBLIC@dol.gov.
Submit comments about this request
by mail or courier to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for DOL–ETA,
Office of Management and Budget,
Room 10235, 725 17th Street NW.,
Washington, DC 20503; by Fax: 202–
395–6881 (this is not a toll-free
number); or by email: OIRA_
submission@omb.eop.gov. Commenters
are encouraged, but not required, to
send a courtesy copy of any comments
by mail or courier to the U.S.
Department of Labor—OASAM, Office
of the Chief Information Officer, Attn:
Departmental Information Compliance
Management Program, Room N1301,
200 Constitution Avenue NW.,
Washington, DC 20210; or by email:
DOL_PRA_PUBLIC@dol.gov.
SUMMARY:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
E:\FR\FM\14JYN1.SGM
14JYN1
Agencies
[Federal Register Volume 79, Number 134 (Monday, July 14, 2014)]
[Notices]
[Page 40781]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16317]
[[Page 40781]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Research
Triangle Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before September 12, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to section 7(g) of 28 CFR
part 0, subpart R, Appendix.
In accordance with 21 CFR 1301.33(a), this is notice that on April
4, 2014, Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann
Building East Institute Drive, P.O. Box 12194, Research Triangle Park,
North Carolina 27709, applied to be registered as a bulk manufacturer
of the following basic classes controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. II
------------------------------------------------------------------------
The company will manufacture marihuana and cocaine derivatives for
use by their customers in analytical kits, reagents, and reference
standards as directed by the National Institute on Drug Abuse.
Dated: July 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-16317 Filed 7-11-14; 8:45 am]
BILLING CODE 4410-09-P